Biotech · Public company · Pasadena, CA, US
Arrowhead Pharmaceuticals, Inc.
Ticker ARWR · SEC CIK 0000879407
Track this companyFree. Adds Arrowhead Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials174 recruiting or active
Pipeline programs17From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline17
- PlozasiranPhase 3 · Severe HypertriglyceridemiaClinicalTrials.gov · fetched Nov 12, 2026
- PlozasiranPhase 3 · Familial ChylomicronemiaClinicalTrials.gov · fetched Nov 12, 2026
- Plozasiran InjectionPhase 3 · HypertriglyceridemiaClinicalTrials.gov · fetched Nov 12, 2026
- Plozasiran InjectionPhase 3 · Severe HypertriglyceridemiaClinicalTrials.gov · fetched Nov 12, 2026
- ZodasiranPhase 3 · Homozygous Familial HypercholesterolemiaClinicalTrials.gov · fetched Nov 12, 2026
- zodasiran InjectionPhase 3 · Homozygous Familial HypercholesterolemiaClinicalTrials.gov · fetched Nov 12, 2026
- ARC-520Phase 2 · Chronic Hepatitis BClinicalTrials.gov · fetched Nov 12, 2026
- ARO-ANG 3 InjectionPhase 2 · Homozygous Familial HypercholesterolemiaClinicalTrials.gov · fetched Nov 12, 2026
- ARO-ANG3Phase 2 · Mixed DyslipidemiaClinicalTrials.gov · fetched Nov 12, 2026
- ARO-APOC3Phase 2 · Mixed DyslipidemiaClinicalTrials.gov · fetched Nov 12, 2026
- ARO-APOC3Phase 2 · Severe HypertriglyceridemiaClinicalTrials.gov · fetched Nov 12, 2026
- ARO-APOC3Phase 2 · DyslipidemiasClinicalTrials.gov · fetched Nov 12, 2026
- diphenhydraminePhase 2 · Chronic Hepatitis BClinicalTrials.gov · fetched Nov 12, 2026
- EntecavirPhase 2 · Chronic Hepatitis BClinicalTrials.gov · fetched Nov 12, 2026
- Fazisiran InjectionPhase 2 · Alpha 1-Antitrypsin DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
- TenofovirPhase 2 · Chronic Hepatitis BClinicalTrials.gov · fetched Nov 12, 2026
- ARO-HIF2Phase 1 · Clear Cell Renal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials17
- Study of Zodasiran in Adolescent Participants With Homozygous Familial HypercholesterolemiaPHASE3 · RECRUITING · started Oct 1, 2026ClinicalTrials.gov NCT07473843 · fetched Nov 12, 2026
- A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)PHASE3 · ACTIVE_NOT_RECRUITING · started Jun 17, 2025ClinicalTrials.gov NCT07037771 · fetched Nov 12, 2026
- Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute PancreatitisPHASE3 · RECRUITING · started Apr 24, 2025ClinicalTrials.gov NCT06880770 · fetched Nov 12, 2026
- Long-Term Safety and Efficacy of Plozasiran in Adults With HypertriglyceridemiaPHASE3 · ACTIVE_NOT_RECRUITING · started Apr 9, 2025ClinicalTrials.gov NCT06822790 · fetched Nov 12, 2026
- Study of Plozasiran in Adults With Severe HypertriglyceridemiaPHASE3 · COMPLETED · started Jul 23, 2024ClinicalTrials.gov NCT06347016 · fetched Nov 12, 2026
- Study of Plozasiran (ARO-APOC3) in Adults With Severe HypertriglyceridemiaPHASE3 · COMPLETED · started Jul 22, 2024ClinicalTrials.gov NCT06347003 · fetched Nov 12, 2026
- Phase 3 Study of Plozasiran in Adults With HypertriglyceridemiaPHASE3 · COMPLETED · started May 21, 2024ClinicalTrials.gov NCT06347133 · fetched Nov 12, 2026
- Study of ARO-APOC3 in Adults With DyslipidemiaPHASE2 · COMPLETED · started Jul 7, 2022ClinicalTrials.gov NCT05413135 · fetched Nov 12, 2026
- Study of ARO-ANG3 in Participants With Homozygous Familial Hypercholesterolemia (HOFH)PHASE2 · TERMINATED · started Apr 22, 2022ClinicalTrials.gov NCT05217667 · fetched Nov 12, 2026
- Study of ARO-APOC3 (Plozasiran) in Adults With Familial Chylomicronemia Syndrome (FCS)PHASE3 · COMPLETED · started Dec 14, 2021ClinicalTrials.gov NCT05089084 · fetched Nov 12, 2026
- Study of Plozasiran (ARO-APOC3) in Adults With Mixed DyslipidemiaPHASE2 · COMPLETED · started Sep 28, 2021ClinicalTrials.gov NCT04998201 · fetched Nov 12, 2026
- Study of ARO-ANG3 in Adults With Mixed DyslipidemiaPHASE2 · COMPLETED · started Jun 28, 2021ClinicalTrials.gov NCT04832971 · fetched Nov 12, 2026
- Study to Evaluate ARO-APOC3 in Adults With Severe HypertriglyceridemiaPHASE2 · COMPLETED · started May 31, 2021ClinicalTrials.gov NCT04720534 · fetched Nov 12, 2026
- Study of ARO-HIF2 in Patients With Advanced Clear Cell Renal Cell CarcinomaPHASE1 · COMPLETED · started Aug 17, 2020ClinicalTrials.gov NCT04169711 · fetched Nov 12, 2026
- Safety, Tolerability and Pharmacodynamic Effect of Fazirsiran (TAK-999, ARO-AAT)PHASE2 · COMPLETED · started Aug 7, 2019ClinicalTrials.gov NCT03945292 · fetched Nov 12, 2026
- Study of ARC-520 in Participants With Hepatitis B Virus e Antigen (HBeAg) Positive Chronic Hepatitis B VirusPHASE2 · TERMINATED · started Aug 1, 2015ClinicalTrials.gov NCT02452528 · fetched Nov 12, 2026
- Treatment Protocol of Plozasiran in Adults With High-Risk Severe Hypertriglyceridemia (SHTG) and in Adults and Adolescents With FCSAVAILABLEClinicalTrials.gov NCT06796426 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Nov 4, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 4, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 4, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 16, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 20, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Feb 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Feb 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jan 12, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jan 9, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jan 6, 2026 · fetched Nov 12, 2026